Literature DB >> 16105699

RNA interference (RNAi) for the silencing of extracellular serine proteases genes in Acanthamoeba: molecular analysis and effect on pathogenecity.

Jacob Lorenzo-Morales1, Antonio Ortega-Rivas, Pilar Foronda, Néstor Abreu-Acosta, David Ballart, Enrique Martínez, Basilio Valladares.   

Abstract

Silencing of extracellular serine protease genes was undertaken by interference RNA (RNAi). Chemically synthesized, small interfering RNA (siRNA) were highly specific and efficient in silencing the catalytic domain of extracellular serine proteases of Acanthamoeba. In order to confirm the silencing phenomenon, the extracellular serine protease activities in RNAi-treated parasites were compared to non-treated parasites, using zymography profiles, Acanthamoeba-conditioned medium (ACM) protease activity, cytotoxicity assays and extracellular serine protease mRNA levels analysis. Zymography profiles showed a decrease in the extracellular protease levels in the moderate pathogenic and pathogenic strains, after treatment with siRNA. These results were supported after the ACM protease activity and CPE assays were performed in all studied isolates, showing a lower protease activity or cytotoxicity both in the pathogenic and moderate pathogenic strains treated with RNAi. These results support that extracellular serine proteases are directly involved in the pathogenesis and virulence of Acanthamoeba.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16105699     DOI: 10.1016/j.molbiopara.2005.07.001

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  15 in total

1.  Long-term, low-maintenance storage of Acanthamoeba strains.

Authors:  Jacob Lorenzo-Morales; Sutherland K Maciver
Journal:  Parasitol Res       Date:  2006-05-19       Impact factor: 2.289

2.  Glycogen phosphorylase in Acanthamoeba spp.: determining the role of the enzyme during the encystment process using RNA interference.

Authors:  Jacob Lorenzo-Morales; Jarmila Kliescikova; Enrique Martinez-Carretero; Luis Miguel De Pablos; Bronislava Profotova; Eva Nohynkova; Antonio Osuna; Basilio Valladares
Journal:  Eukaryot Cell       Date:  2008-01-25

3.  Evaluation of Acanthamoeba myosin-IC as a potential therapeutic target.

Authors:  Carmen M Martín-Navarro; Jacob Lorenzo-Morales; Atteneri López-Arencibia; María Reyes-Batlle; José E Piñero; Basilio Valladares; Sutherland K Maciver
Journal:  Antimicrob Agents Chemother       Date:  2014-01-27       Impact factor: 5.191

4.  Amoebicidal Activity of Caffeine and Maslinic Acid by the Induction of Programmed Cell Death in Acanthamoeba.

Authors:  Carmen M Martín-Navarro; Atteneri López-Arencibia; Ines Sifaoui; María Reyes-Batlle; Emilie Fouque; Antonio Osuna; Basilio Valladares; José E Piñero; Yann Héchard; Sutherland K Maciver; Jacob Lorenzo-Morales
Journal:  Antimicrob Agents Chemother       Date:  2017-05-24       Impact factor: 5.191

5.  Therapeutic potential of a combination of two gene-specific small interfering RNAs against clinical strains of Acanthamoeba.

Authors:  Jacob Lorenzo-Morales; Carmen M Martín-Navarro; Atteneri López-Arencibia; María A Santana-Morales; Raquel N Afonso-Lehmann; Sutherland K Maciver; Basilio Valladares; Enrique Martínez-Carretero
Journal:  Antimicrob Agents Chemother       Date:  2010-09-20       Impact factor: 5.191

6.  Early diagnosis of amoebic keratitis due to a mixed infection with Acanthamoeba and Hartmannella.

Authors:  Jacob Lorenzo-Morales; Enrique Martínez-Carretero; Ninive Batista; Jorge Alvarez-Marín; Yasmina Bahaya; Julia Walochnik; Basilio Valladares
Journal:  Parasitol Res       Date:  2007-09-21       Impact factor: 2.289

7.  Voriconazole as a first-line treatment against potentially pathogenic Acanthamoeba strains from Peru.

Authors:  Alfonso Martín Cabello-Vílchez; Carmen M Martín-Navarro; Atteneri López-Arencibia; María Reyes-Batlle; Ines Sifaoui; Basilio Valladares; José E Piñero; Jacob Lorenzo-Morales
Journal:  Parasitol Res       Date:  2013-11-22       Impact factor: 2.289

8.  Inhibition of 3-hydroxy-3-methylglutaryl-coenzyme A reductase and application of statins as a novel effective therapeutic approach against Acanthamoeba infections.

Authors:  Carmen María Martín-Navarro; Jacob Lorenzo-Morales; Rubén P Machin; Atteneri López-Arencibia; José Manuel García-Castellano; Isabel de Fuentes; Brendan Loftus; Sutherland K Maciver; Basilio Valladares; José E Piñero
Journal:  Antimicrob Agents Chemother       Date:  2012-10-31       Impact factor: 5.191

Review 9.  An update on Acanthamoeba keratitis: diagnosis, pathogenesis and treatment.

Authors:  Jacob Lorenzo-Morales; Naveed A Khan; Julia Walochnik
Journal:  Parasite       Date:  2015-02-18       Impact factor: 3.000

Review 10.  Acanthamoeba and Dictyostelium as Cellular Models for Legionella Infection.

Authors:  A Leoni Swart; Christopher F Harrison; Ludwig Eichinger; Michael Steinert; Hubert Hilbi
Journal:  Front Cell Infect Microbiol       Date:  2018-03-02       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.